The Hormone Replacement Therapy Drug Tibolone Acts Very Similar to Medroxyprogesterone Acetate in an Estrogen-And Progesterone-Responsive Endometrial Cancer Cell Line

Journal of Molecular Endocrinology - United Kingdom
doi 10.1677/jme.1.02057
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Effect of Medroxyprogesterone Acetate on Sex Hormone-Binding Globulin mRNA Expression in the Human Endometrial Cancer Cell Line Ishikawa

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
1998English

Progesterone Therapy in Endometrial Cancer

American Journal of Obstetrics and Gynecology
GynecologyObstetrics
2018English

Differential Effects of Estrogen and Micronized Progesterone or Medroxyprogesterone Acetate on Cognition in Postmenopausal Women

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2011English

Hormone Replacement Therapy and the Risk of Endometrial Cancer: A Summary

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1989English

Comparative Actions of Progesterone, Medroxyprogesterone Acetate, Drospirenone and Nestorone on Breast Cancer Cell Migration and Invasion

BMC Cancer
Cancer ResearchOncologyGenetics
2008English

Body Mass and Endometrial Cancer Risk by Hormone Replacement Therapy and Cancer Subtype

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2008English

Body Mass Index, Hormone Replacement Therapy, and Endometrial Cancer Risk: A Meta-Analysis

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2010English

An Evaluation of High-Dose Medroxyprogesterone Acetate (MPA) Therapy in Women With Advanced Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
1984English

Progesterone Isoforms and Endometrial Cancer

Journal of the Society for Gynecologic Investigation
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy